Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Opioids Can't Stop Califf Confirmation

This article was originally published in The Pink Sheet Daily

Executive Summary

Commissioner nominee draws overwhelming Senate support – but also bipartisan opposition to FDA's policy on pain products.


Related Content

FDA's Next Commissioner: Will Trump Follow Hamburg Or McClellan 'Schedule'?
Califf Nomination Suffers 'Pile On': What Can FDA Do To Break Logjam?
Califf Nomination May Show Confidence In His Bipartisan Appeal
FDA Staying The Course Under Ostroff; Hamburg’s Concerns Will Remain Focus


Related Companies